Full-Time

Director/Senior Director of Search & Evaluation

Confirmed live in the last 24 hours

1910 Genetics

11-50 employees

AI-driven drug discovery and development

AI & Machine Learning

Biotechnology

Senior

Cambridge, MA, USA

Requirements

Ph.D., M.D., or combined MD/PhD in the life sciences
Minimum of 5 years of Search & Evaluation experience in a Sell-Side Business Development Role
A strong deal sheet demonstrating a track record of identifying, evaluating, structuring, negotiating, closing, and executing sell-side BD deals with biopharma companies
Minimum of 3 years of Drug Discovery & Development experience in the biopharma industry
Experience working in a biotech startup
Exposure to deal structuring, negotiations, transactions, closing, and alliance management
Superior written and spoken communication skills
Excitement about working in a resource-constrained startup environment
Strong team player with mentorship skills
Ability to work independently with a sense of urgency and ownership

Responsibilities

Partnering with all scientific and technical teams at 1910 Genetics
Extracting key differentiation of 1910’s platforms and developing it into a coherent narrative
Positioning 1910’s platforms in the AI for drug discovery competitive landscape
Strategically selling 1910’s platforms to stakeholders of any audience
Working in a resource-constrained startup environment
Providing ample opportunity for accelerated career growth
Being a strong team player and giving/receiving mentorship
Working independently with a sense of urgency and ownership

Company Overview

1910 Genetics is the only company that has built a synergistic, dual-purpose small and large molecule platform that integrates artificial intelligence (AI), computation, and biological automation to design drug-like molecules better, faster, and cheaper than traditional approaches.

Based in the Seaport District of Boston, 1910 Genetics is a Series A stage biotechnology startup that was founded in 2018 and is backed by prestigious investors, including M12-Microsoft’s Venture Fund, Sam Altman – the CEO of OpenAI (makers of ChatGPT), Playground Global, Y Combinator, New Ventures Funds (Scientia Ventures), and many others.

At 1910 Genetics, we first establish an understanding of the molecular basis of disease to the granularity at which the world understands sickle cell anemia. This understanding centers biology as our North Star and drives our integration of artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics.

Recent advances in computational technologies have placed historically “undruggable” targets within therapeutic reach. But at 1910 Genetics, we often say “Biology is King,” meaning that computational technologies are only impactful in drug discovery when driven by experimental biology. Our platforms’ scale and breadth empower us to be therapeutic area-agnostic with programs ranging from neuroscience and immunology to infectious disease and oncology, to name a few.

Based in the Seaport District of Boston, 1910 Genetics is a Series A stage biotechnology startup that was founded in 2018, and is backed by prestigious investors including M12-Microsoft’s Venture Fund, Sam Altman – the CEO of OpenAI (makers of ChatGPT), Playground Global, Y Combinator, New Ventures Funds (Scientia Ventures), and many others.

THE ROLE & RESPONSIBILITIES

The Director of Search & Evaluation would be a core member of the Business Development team and would blend a strong scientific background with an impressive track record of sell-side Search & Evaluation experience that has resulted in transformative strategic partnerships for biotech companies who are selling platforms, technologies, drug assets, etc. to pharmaceutical companies.

The ideal individual would partner with all scientific and technical teams at 1910 Genetics (AI Research, ML Engineering, Software Engineering, Computational Chemistry, Medicinal Chemistry, Biology, Pharmacology, Preclinical Development) to extract the key differentiation of 1910’s platforms, develop it into a coherent narrative, position it in the ever-evolving AI for drug discovery competitive landscape, and strategically sell 1910’s platforms to stakeholders of any audience (scientists, business executives, etc.)

Ideally you have...

Ph.D., M.D., or combined MD/PhD in the life sciences is required
Minimum of 5 years of Search & Evaluation experience in a Sell-Side Business Development Role that requires selling platforms, technologies, drug assets to pharmaceutical companies
A strong deal sheet that demonstrates a track record of identifying, evaluating, structuring, negotiating, closing, and executing sell-side BD deals with biopharma companies
Minimum of 3 years of Drug Discovery & Development and experience in the biopharma industry
Experience working in a biotech startup is ideal
Beyond expertise in Search & Evaluation, exposure to other aspects of the end-to-end sell-side BD process, including but not limited to: deal structuring, negotiations, transactions, closing, and alliance management
Superior written and spoken communication skills that is required to credibly sell novel platforms and technologies to biopharma partners
Excited about working in a resource-constrained startup environment that provides ample opportunity for accelerated career growth
A strong team player, who can give and receive mentorship
Able to work independently with a sense of urgency and ownership

Compensation & Benefits

Competitive Compensation Package
Above market benefits
Generous vacation and parental leave
Super cool team building activities
Flexible work schedule (3 days onsite)
Great colleagues

1910 Genetics

View

Website

View Company Profile

At 1910 Genetics, they employ a pioneering combination of AI, computation, and biological automation to enhance the drug development process, specializing in both small molecule and protein therapeutics across various therapeutic areas. Their ability to streamline the entire early drug discovery process with platforms like ELVIS™ and ROSALYND™ positions them as a leader in accelerating therapeutic innovations. This focus not only promotes an advanced technological environment but also cultivates a culture of cutting-edge research and development, making it an excellent workplace for those passionate about transforming healthcare through science.

Company Stage

Series A

Total Funding

$34.7M

Headquarters

Boston, Massachusetts

Founded

2018

Growth & Insights

Headcount

6 month growth

↑ 8%

1 year growth

↓ -3%

2 year growth

↑ 8%

Benefits

Extremely generous equity package

Competitive salary

Healthcare benefits

Generous vacation and parental leave

Super cool team building activities

Flexible work schedule